Schedule a consultation with Heally today to discuss your GLP-1 treatment experience and develop an energy management plan that works for you
Bariatric surgery typically leads to greater overall and more sustained weight loss
The pursuit of health is never entirely innocent. Ivan Illich A Timeline of Trials It began quietly in 2005 with exenatidethe first GLP-1 receptor agonist
Glucagon-like peptide-1 (GLP-1) receptor agonists are licensed for type 2 diabetes and weight management, not inflammatory conditions
Ensuring adequate calcium, vitamin D, and protein intake, along with weight-bearing exercise, helps preserve bone health during weight reduction
Su principio activo, tirzepatida, combina la accin GLP-1 con la del GIP, lo que le da un doble efecto: regula glucosa y reduce apetito, pero tambin mejora cmo el cuerpo gestiona la grasa